{
  "@context": {
    "bioagents": "https://bio.agents/ontology/",
    "bsc": "http://bioschemas.org/",
    "bsct": "http://bioschemas.org/types/",
    "dct": "http://purl.org/dc/terms/",
    "edam": "http://edamontology.org/",
    "owl": "http://www.w3.org/2002/07/owl#",
    "rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
    "rdfs": "http://www.w3.org/2000/01/rdf-schema#",
    "sc": "http://schema.org/",
    "xsd": "http://www.w3.org/2001/XMLSchema#"
  },
  "@graph": [
    {
      "@id": "https://doi.org/10.1186/S12967-019-2010-4",
      "@type": "sc:CreativeWork"
    },
    {
      "@id": "https://bio.agents/interface-CancerDAP",
      "@type": "sc:SoftwareApplication",
      "dct:conformsTo": "https://bioschemas.org/profiles/ComputationalAgent/0.6-DRAFT",
      "sc:additionalType": "Web application",
      "sc:applicationSubCategory": [
        {
          "@id": "edam:topic_0208"
        },
        {
          "@id": "edam:topic_3379"
        },
        {
          "@id": "edam:topic_3295"
        }
      ],
      "sc:citation": [
        "pmcid:PMC6685260",
        "pubmed:31387579",
        {
          "@id": "https://doi.org/10.1186/S12967-019-2010-4"
        }
      ],
      "sc:description": "Identifying subpathway signatures for individualized anticancer drug response by integrating multi-omics data | CancerDAP is a database molecularly characterizing subpathways involved in cellular response to 191 anticancer drugs | 1 Prospect the detailed information of each subpathway related to corresponding anticancer drug; 2 | CancerDAP has been formally launched and is freely available at:",
      "sc:featureList": [
        {
          "@id": "edam:operation_2436"
        },
        {
          "@id": "edam:operation_3557"
        }
      ],
      "sc:name": "interface-CancerDAP",
      "sc:url": "http://bio-bigdata.hrbmu.edu.cn/CancerDAP/"
    }
  ]
}